Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
William Aliski Insider Profile
4 Followers
William Aliski, Director at Ultragenyx Pharmaceutical, holds 96.67K shares in X4 Pharmaceuticals (Ticker: XFOR), holds 0.00 shares in Applied Genetic Technologies (Ticker: AGTC), holds 147.66K shares in Ultragenyx Pharmaceutical (Ticker: RARE).
William Aliski Ultragenyx Pharmaceutical (RARE)Director
Ultragenyx Pharmaceutical (RARE)
Director
Ranked #79,229 out of 99,335 Corporate Insiders
Profitable Transactions
4 out of 10 Profitable Transactions
Average Return
-14.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that William Aliski holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Feb 23, 2021 - Feb 23, 2022
Return:+53.70%
The most profitable trade made by William Aliski
William Aliski's Trading History
Ultragenyx Pharmaceutical
Jun 28, 2021
Director
Uninformative Buy
―
$6.98M
Applied Genetic Technologies
Dec 01, 2022
―
Uninformative Sell
―
$0.00
X4 Pharmaceuticals
Jun 11, 2024
Director
Uninformative Buy
―
$32.67K
List of latest transactions for each holding click on a transaction to see William Aliski's performance on stock
You May Also Like
William Aliski insider profile FAQ
What is the percentage of profitable transactions made by William Aliski?
The percentage of profitable transactions made by William Aliski is 40%.
What is the average return per transaction made by William Aliski?
The average return per transaction made by William Aliski is -14.30%.
What stocks does William Aliski hold?
William Aliski holds: RARE, AGTC, XFOR stocks.
What was William Aliski’s latest transaction?
William Aliski latest transaction was an Uninformative Buy of ―.
What was William Aliski's most profitable transaction?
William Aliski’s most profitable transaction was an Informative Sell of RARE stock on February 23, 2021. The return on the trade was 53.70%.
What is William Aliski's role in Ultragenyx Pharmaceutical?
William Aliski's role in Ultragenyx Pharmaceutical is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.